The severity of COVID-19 in children on immunosuppressive medication
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2020/07/01
-
Indian UGC (journal)
-
Refrences4
-
Citations4
-
Matko Marlais
-
Tanja Wlodkowski
-
Marina Vivarelli
-
Lars Pape
-
Burkhard Tönshoff
-
Franz Schaefer
-
Kjell Tullus
Cite
Marlais, Matko, et al. “The Severity of COVID-19 in Children on Immunosuppressive Medication”. The Lancet Child &Amp; Adolescent Health, vol. 4, no. 7, 2020, pp. e17-e18, https://doi.org/10.1016/s2352-4642(20)30145-0.
Marlais, M., Wlodkowski, T., Vivarelli, M., Pape, L., Tönshoff, B., Schaefer, F., & Tullus, K. (2020). The severity of COVID-19 in children on immunosuppressive medication. The Lancet Child &Amp; Adolescent Health, 4(7), e17-e18. https://doi.org/10.1016/s2352-4642(20)30145-0
Marlais M, Wlodkowski T, Vivarelli M, Pape L, Tönshoff B, Schaefer F, et al. The severity of COVID-19 in children on immunosuppressive medication. The Lancet Child & Adolescent Health. 2020;4(7):e17-e18.
Journal Categories
Medicine
Medicine (General)
Medicine
Pediatrics
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy | JAMA |
| 3,537 | 2020 |
| Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study | The Lancet Infectious Diseases |
| 2020 | |
| Estimates of the severity of coronavirus disease 2019: a model-based analysis | The Lancet Infectious Diseases |
| 2020 | |
| COVID-19 and paediatric inflammatory bowel diseases: global experience and provisional guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN | Journal of Pediatric Gastroenterology and Nutrition |
| 2020 |
Refrences Analysis
The category
Medicine: Internal medicine: Infectious and parasitic diseases 4
is the most frequently represented among the references in this article. It primarily includes studies from The Lancet Infectious Diseases The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
COVID-19 in Children with Chronic Kidney Disease; Does it Differ
Much? | Klinische Pädiatrie |
| 2024 | |
COVID-19 in immunocompromised children and adolescents | Clinical and Experimental Pediatrics |
| 5 | 2023 |
| Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients | Pediatric Nephrology |
| 5 | 2022 |
| Effects of COVID-19 pandemic on pediatric kidney transplant in the United States | Pediatric Nephrology |
| 17 | 2020 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Pediatrics | 4 |
| Medicine: Medicine (General) | 3 |
| Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology | 2 |
The category
Medicine: Pediatrics 4
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Effects of COVID-19 pandemic on pediatric kidney transplant in the United States and was published in 2020. The most recent citation comes from a 2024 study titled COVID-19 in Children with Chronic Kidney Disease; Does it Differ
Much?. This article reached its peak citation in 2024, with 1 citations. It has been cited in 3 different journals, 33% of which are open access. Among related journals, the Pediatric Nephrology cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.